Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4
Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4
Bianca Santomasso, Jaime Gállego Pérez‐Larraya, Nitin Patel, Kevin C. De Braganca et al.
Journal
Blood Cancer Journal
Topics
CAR-T cell therapy research
article
Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4
Bianca Santomasso, Jaime Gállego Pérez‐Larraya, Nitin Patel, Kevin C. De Braganca, Deepu Madduri, Philip Vlummens, Surbhi Sidana, Erika Florendo, Christina Corsale, Nikoletta K. Lendvai, Vicki Plaks, Niels W.C.J. van de Donk, Mythili Koneru, Mathilde C.M. Kouwenhoven, Diana Chen, Katherine Li, Erin Lee, Rocio Montes De Oca, Loreta Marquez, Carolina Lonardi, Ana Slaughter, Paula Rodríguez‐Otero, Jordan Mark Schecter, Helen Varsos, Man Zhao, Tzu‐Min Yeh, Muhammad Akram, Hao Zhao
article en
Abstract
No abstract available for this paper.
Publication Tag
Blood Cancer JournalVol. 15(1)
Institutions
Johnson & Johnson (United States) (US), Memorial Sloan Kettering Cancer Center (US), Johnson & Johnson (Switzerland) (CH), Amsterdam Neuroscience (NL), iQIYI (China) (CN), Johnson Electric (China) (CN), Clinica Universidad de Navarra (ES), Amsterdam University Medical Centers (NL), Vrije Universiteit Amsterdam (NL), Stanford University (US)